Parkinson Disease, Physical Disability
Conditions
Brief summary
The aim of this study is to evaluate the associations of self-compassion and self-efficacy levels with symptom severity, functional status, and quality of life in individuals with Parkinson's disease.
Interventions
This study does not involve any therapeutic intervention. Participants will complete a set of self-report questionnaires assessing self-compassion, self-efficacy, symptom severity, functional status, and quality of life. Data will be collected in a single session for observational analysis.
Sponsors
Acibadem University
Study design
Observational model
COHORT
Time perspective
CROSS_SECTIONAL
Eligibility
Sex/Gender
ALL
Age
40 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Clinical diagnosis of Parkinson's disease * Hoehn and Yahr stage 1-3 * Age 40 to 85 years * Mini-Mental State Examination (MMSE) score ≥24 * Sufficient cognitive function to communicate and complete study assessments * Attending the Movement Disorders Outpatient Clinic, Department of Neurology * Able and willing to provide written informed consent
Exclusion criteria
* Major depressive disorder or psychotic disorder * Advanced dementia * Uncontrolled chronic systemic disease (e.g., diabetes mellitus or hypertension) * Severe cardiovascular or respiratory disease * Additional neurological or orthopedic conditions that may affect assessment performance * Severe visual or hearing impairment that could interfere with study assessments * Inability to cooperate with the physiotherapist during study assessments
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Self-Compassion Scale (SCS) Total Score | Baseline (at the time of questionnaire completion) | Self-Compassion Scale (SCS) total score. The Self-Compassion Scale consists of 26 items scored on a 1- to 5-point Likert scale. Total scores range from 1 to 5 (calculated as the mean of all items), with higher scores indicating greater self-compassion (better outcome). |
| Self-Efficacy for Managing Chronic Disease 6-Item Scale Total Score | Baseline (at the time of questionnaire completion) | Self-Efficacy for Managing Chronic Disease 6-Item Scale total score. The scale consists of 6 items scored from 1 (not at all confident) to 10 (totally confident). The total score is calculated as the mean of the six items, ranging from 1 to 10, with higher scores indicating greater self-efficacy for managing chronic disease (better outcome). |
| Unified Parkinson's Disease Rating Scale (UPDRS) Total Score | Baseline (at the time of questionnaire completion) | Unified Parkinson's Disease Rating Scale (UPDRS) total score. The total score ranges from 0 to 199, with higher scores indicating greater Parkinson's disease severity and worse clinical status (worse outcome). |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Timed Up and Go (TUG) Test Completion Time in Seconds | Baseline (at the time of questionnaire completion) | Functional mobility will be measured using the Timed Up and Go (TUG) test. The time required to stand up from a chair, walk 3 meters, turn, return, and sit down will be recorded in seconds. Longer times indicate poorer functional mobility. |
| Six-Minute Walk Test (6MWT) Distance in Meters | Baseline (at the time of questionnaire completion) | Functional exercise capacity will be measured using the Six-Minute Walk Test (6MWT). The total distance walked in six minutes will be recorded in meters. Greater distances indicate better functional capacity. |
| Mini-Balance Evaluation Systems Test (Mini-BESTest) Total Score | Baseline (at the time of questionnaire completion) | Dynamic balance will be measured using the Mini-Balance Evaluation Systems Test (Mini-BESTest), a 14-item performance-based assessment. Total scores range from 0 to 28, with higher scores indicating better balance performance. |
| Parkinson's Disease Questionnaire-39 (PDQ-39) Total Score | Baseline (at the time of questionnaire completion) | Quality of life will be measured using the Parkinson's Disease Questionnaire-39 (PDQ-39), a validated disease-specific instrument. Total scores range from 0 to 100, with higher scores indicating poorer quality of life. |
Countries
Turkey (Türkiye)
Contacts
CONTACTNuray ALACA
Outcome results
None listed